Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is headquartered in Maple Grove, Minnesota.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:INSP
Previous Symbol
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares21,400,000
Market Cap$0.00
OptionableOptionable
Inspire Medical Systems (NASDAQ:INSP) Frequently Asked Questions
What is Inspire Medical Systems' stock symbol?
Inspire Medical Systems trades on the NASDAQ under the ticker symbol "INSP."
How were Inspire Medical Systems' earnings last quarter?
Inspire Medical Systems (NASDAQ:INSP) released its quarterly earnings results on Tuesday, November, 6th. The company reported ($0.22) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.35) by $0.13. The firm had revenue of $13.10 million for the quarter, compared to analyst estimates of $12.86 million. The business's revenue for the quarter was up 79.9% on a year-over-year basis. During the same period in the previous year, the business posted ($3.42) earnings per share. View Inspire Medical Systems' Earnings History.
When is Inspire Medical Systems' next earnings date?
What guidance has Inspire Medical Systems issued on next quarter's earnings?
Inspire Medical Systems updated its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $47.5-48 million, compared to the consensus revenue estimate of $44.17 million.
What price target have analysts set for INSP?
7 analysts have issued 1-year price objectives for Inspire Medical Systems' stock. Their predictions range from $25.00 to $57.00. On average, they anticipate Inspire Medical Systems' stock price to reach $38.4286 in the next year. This suggests that the stock has a possible downside of 7.1%. View Analyst Price Targets for Inspire Medical Systems.
What is the consensus analysts' recommendation for Inspire Medical Systems?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Inspire Medical Systems.
Has Inspire Medical Systems been receiving favorable news coverage?
Media stories about INSP stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Inspire Medical Systems earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Inspire Medical Systems' key competitors?
Some companies that are related to Inspire Medical Systems include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Electromed (ELMD) and Ellex Medical Lasers (ELXMF).
Who are Inspire Medical Systems' key executives?
Inspire Medical Systems' management team includes the folowing people:
- Mr. Tim Herbert, Chief Exec. Officer and Pres
- Mr. Richard Buchholz, Chief Financial Officer
- Mr. Randy Ban, Sr. VP of Sales and Marketing
- Mr. Sean Cleary, VP of Global Market Devel.
- Mr. Gary A. Goetzke, VP of Health Economics
When did Inspire Medical Systems IPO?
(INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.
When did the company's lock-up period expire?
Inspire Medical Systems' lock-up period expired on Tuesday, October 30th. Inspire Medical Systems had issued 6,750,000 shares in its public offering on May 3rd. The total size of the offering was $108,000,000 based on an initial share price of $16.00. Since the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.
Who are Inspire Medical Systems' major shareholders?
Inspire Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Franklin Resources Inc. (2.88%), BlackRock Inc. (2.56%), Vanguard Group Inc. (1.63%), Vanguard Group Inc (1.63%), Citadel Advisors LLC (0.89%) and Gilder Gagnon Howe & Co. LLC (0.71%). Company insiders that own Inspire Medical Systems stock include Amzak Health Investors, Llc, Jerry C Griffin, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Institutional Ownership Trends for Inspire Medical Systems.
Which institutional investors are selling Inspire Medical Systems stock?
INSP stock was sold by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., Wells Fargo & Company MN, EAM Investors LLC, BlackRock Inc., Pentwater Capital Management LP, TIAA CREF Investment Management LLC and JPMorgan Chase & Co.. Company insiders that have sold Inspire Medical Systems company stock in the last year include Jerry C Griffin, Randy Ban and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
Which institutional investors are buying Inspire Medical Systems stock?
INSP stock was purchased by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Osterweis Capital Management Inc., American Century Companies Inc., Columbus Circle Investors, Bellevue Group AG, Franklin Resources Inc., Macquarie Group Ltd. and Credit Suisse AG. Company insiders that have bought Inspire Medical Systems stock in the last two years include Amzak Health Investors, Llc, Marilyn C Nelson, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View Insider Buying and Selling for Inspire Medical Systems.
How do I buy shares of Inspire Medical Systems?
Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Inspire Medical Systems' stock price today?
One share of INSP stock can currently be purchased for approximately $41.36.
What is Inspire Medical Systems' official website?
MarketBeat Community Rating for Inspire Medical Systems (NASDAQ INSP)
MarketBeat's community ratings are surveys of what our community members think about Inspire Medical Systems and other stocks. Vote "Outperform" if you believe INSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
